Pliant Therapeutics
PLRX
PLRX
140 hedge funds and large institutions have $78.5M invested in Pliant Therapeutics in 2025 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
34% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 50
83% less funds holding in top 10
Funds holding in top 10: 6 → 1 (-5)
91% less capital invested
Capital invested by funds: $853M → $78.5M (-$774M)
Holders
140
Holding in Top 10
1
Calls
$214K
Puts
$10K
Top Buyers
| 1 | +$8.1M | |
| 2 | +$4.05M | |
| 3 | +$3.22M | |
| 4 |
Morgan Stanley
New York
|
+$3.06M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.72M |
Top Sellers
| 1 | -$42.1M | |
| 2 | -$26.5M | |
| 3 | -$22.1M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$17.3M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$16.9M |
